Insight

Sana Sukhun: SHR-A1811 demonstrating non-inferiority to the standard quadruple therapy in early Breast Cancer

Sana Sukhun and Aleix Prat

Dec 13, 2024, 17:04

Sana Sukhun: SHR-A1811 demonstrating non-inferiority to the standard quadruple therapy in early Breast Cancer

Sana Sukhun, Co-Chair of RSG Committee of ASCO for Metastatic Breast Cancer, made the following post on X:

“Aleix Prat discusses promising Asian data especially from Fudan University Shanghai Cancer Centre with antibody drug conjugate SHR-A1811 demonstrating non-inferiority to the standard quadruple therapy in early Breast Cancer.”

Sana Sukhun

Aleix Prat Breast Cancer cancer Fudan University OncoDaily Oncology Sana Sukhun Shanghai Cancer Centre

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Science

Feb 22, 2025, 16:16

Angela Lamarca: Current management of advanced HCC

Blog

Feb 22, 2025, 16:04

Eric Lehrer: Role of WBRT in multifocal LGG

Science

Feb 22, 2025, 16:00

Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM

Blog

Feb 22, 2025, 15:54

Patrick Forde: Great day for lung cancer care

Science

Feb 22, 2025, 15:48

Shankar Siva: Whats new in stage IV cancer?

Science

Feb 22, 2025, 15:33

Updated ESMO Clinical Practice Guideline on Hepatocellular Carcinoma

Science

Feb 22, 2025, 15:14

Erman Akkus: Stage specific characterization of early-onset colorectal cancer

Blog

Feb 22, 2025, 15:04

John Gordon: Successful CAR Tcell Therapy - "It's a Bug's Life"

Blog

Feb 22, 2025, 14:43

Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?

Science

Feb 22, 2025, 14:10

Yan Leyfman: Advancing CAR T-Cell Therapy - Off-the-Shelf Allogeneic Approach

Science

Feb 22, 2025, 13:28

Elvina Almuradova: Immunotherapy for HPV-Associated Cancers

Opinion

Feb 22, 2025, 13:10

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding